There are quite a few concerns that we should be flagging when it comes to even generic GLP-1s, from Ozempic to Mounjaro.
The important thing to recognize here is that I'm very concerned about online pharmaceutical sales and the cost of Canada having a lower cost for these medicines. We've seen before that prescriptions happening in British Columbia are being filled in Nova Scotia, and 17,000 of them are going to the States. When we have this at a lower level, we could see a shortage of those products for Canadians.
If you talk to the pharmaceutical companies involved in this and look at the patient voice.... We're all really concerned and raising the flag here at a committee, asking that we find ways to protect Canadian supply to make sure that the lower cost is then applied to Canadians and not shared globally.